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ABSTRACT   
 
ZIC2 mutation is known to cause holoprosencephaly (HPE). A subset of ZIC2 HPE probands 
harbour cardiovascular and visceral anomalies suggestive of laterality defects. 3D-imaging 
of novel mouse Zic2 mutants uncovers, in addition to HPE, laterality defects in lungs, heart, 
vasculature and viscera.  A strong bias towards right isomerism indicates a failure to 
establish left identity in the lateral plate mesoderm (LPM), a phenotype that cannot be 
explained simply by the defective ciliogenesis previously noted in Zic2 mutants. Gene 
expression analysis showed that the left-determining NODAL-dependent signalling cascade 
fails to be activated in the LPM, and that the expression of Nodal at the node, which normally 
triggers this event, is itself defective in these embryos. Analysis of ChiP-seq data, in vitro 
transcriptional assays and mutagenesis reveals a requirement for a low-affinity ZIC2 binding 
site for the activation of the Nodal enhancer HBE, which is normally active in node precursor 
cells. These data show that ZIC2 is required for correct Nodal expression at the node and 
suggest a model in which ZIC2 acts at different levels to establish LR asymmetry, promoting 
both the production of the signal that induces left side identity and the morphogenesis of the 
cilia that bias its distribution. 
 
 
INTRODUCTION 
 
ZIC2 mutation is one of four principal genetic risk factors for holoprosencephaly (HPE), the 
most common structural brain disease1-3. A similar HPE phenotype is seen in mice 
homozygous either for the ethylnitrosourea (ENU) mutant allele Zic2ku 4 or a hypomorphic 
allele, Zic2tm1Jaru 5. The midline organiser known as the node, which forms at the leading 
edge of the primitive streak at the end of gastrulation, plays a central role in the generation 
of mesendodermal structures required to pattern the neural tube, such as the pre-chordal 
plate (PCP) and the notochord. Zic2 is transiently expressed at the node from E7.0 to E7.56.  
Development of the PCP is impaired in the Zic2ku mutant at the late-streak stage 4. Nodal, a 
member of the TGFβ family which signals via SMAD2, 3, is expressed in the epiblast giving 
rise to the primitive streak and in the primitive streak itself. It is required for primitive streak 
formation as well as for that of the node and of node-derived mesendoderm7. An epistatic 
genetic interaction exists between Nodal and Zic2 in forebrain development8.  
 
Laterality of the heart and viscera is also determined by the NODAL pathway. Bilateral 
symmetry is broken through generation of a leftward fluid flow by cilia within the node9,10. 
Nodal is initially expressed bilaterally at the node within perinodal cells (at E7.5 in mouse), 
but in response to the nodal flow, this expression is reinforced in left perinodal cells, thus 
becoming asymmetric11,12. NODAL produced in perinodal cells is required to trigger its own 
expression in the left lateral plate mesoderm (LPM) 13, where it induces the expression of 
Lefty2 14, a NODAL antagonist, and Pitx2c 15,16. Pitx2c expression in the left LPM 
determines left-sided identity in mesoderm derivatives. In the absence of Pitx2c expression 
the default pattern is that of two morphologically right sides, a condition known as right-
isomerism. Ectopic activation of Pitx2c in the right lateral mesoderm only results in situs 
inversus whereas bilateral expression of Pitx2c results in two morphologically left sides, 
known as left-isomerism. These phenotypes can be distinguished by examination of lung 
lobulation, atrial morphology and other characters17. The establishment of Left-Right (LR) 
polarity is essential for key aspects of cardiovascular, thoracic and abdominal development. 
It determines the lateralised identity of atria and lungs, influences looping morphogenesis of 
the linear heart tube and the gut, directs asymmetric remodelling of the vascular system and 
determines the positioning of visceral organs such as stomach and pancreas17-21.  Mutations 
mapping to NODAL pathway genes are associated with heterotaxy22,23, a condition 
characterized by discordant LR arrangement of internal organs which accounts for 
approximately 3% of all congenital heart disease22.   
 
Cardiac malformations have been noted amongst a number of extra-craniofacial anomalies 
reported in HPE patients with ZIC2 mutation, occurring in 9-14% of probands 2,3, but have 
not previously been described in detail.  We hypothesise these may result from an 
underlying laterality defect. The Zic2ku mutant shows randomised direction of heart tube 
looping during cardiac morphogenesis24, supporting this hypothesis. These embryos exhibit 
mid-gestation lethality, preventing a more detailed study of laterality defects24. Nodal cilia are 
shorter and morphologically abnormal in the Zic2ku mutant suggesting that Zic2 may function 
during cilia morphogenesis24. Expression of Nodal at the node and of downstream genes in 
the LPM is reduced in the Zic2ku mutant24, but ectopic right-sided or bilateral expression, 
which is present in iv embryos with nodal cilia defects12,25, is not observed. 
 
Zic2 is also expressed earlier in development and is present in both embryonic (ESC) and 
epiblast (EpiSC) stem cells. ZIC2 is bound to the Nodal locus in both cell types26,27. EpiSCs 
have been shown to resemble cells from the anterior primitive streak28, from which the node 
is derived. ZIC2 appears to play a central role in the transition from the naive pluripotent 
state of ESCs to the primed pluripotent state of EpiSCs26,29 and has been proposed to act as 
a “pioneer factor” that functions to seed enhancers, recruiting additional transcription factors 
in order to prime loci for transcriptional activation at a later stage26. The MDB3-NURD 
chromatin remodelling complex is associated with ZIC2 at a subset of binding sites in 
ESCs27, this complex is known to play a role in fine-tuning dynamic expression of bivalent 
enhancers during development30, consistent with a role for ZIC2 in such a priming process. 
 
Here, we examine clinical data and show that the cardiovascular, pulmonary and visceral 
phenotypes of ZIC2 HPE patients are consistent with an underlying laterality defect.  We 
identify a novel Zic2 ENU mouse mutant in a screen for cardiovascular laterality phenotypes. 
We use 3D imaging to characterise in detail the phenotype of this mutant and that of a series 
of Zic2 alleles generated by TALEN gene editing31, revealing a complex set of 
cardiovascular, thoracic and abdominal malformations, in addition to the previously-
described holoprosencephaly and heart tube looping phenotypes. Analysis of the phenotype 
reveals a strong bias towards right isomerism, indicative of defective left-sided identity 
specification during development.  This is supported by gene expression data revealing 
weak or absent Nodal node expression and loss of downstream gene expression in the 
LPM. We use in vitro assays to demonstrate that ZIC2 can activate transcription from Nodal 
enhancer reporters. Our data suggest that ZIC2 acts upstream of Nodal expression at the 
node, possibly to prime the gene locus for the subsequent activation of its expression there. 
Together with a previous study that identified a role for ZIC2 in ciliogenesis, our results 
suggest a model in which ZIC2 acts at multiple levels during the establishment of laterality, 
upstream of genes and events that are critical for the process to take place. 
 
 
RESULTS 
 
Cardiovascular and pulmonary malformations in human ZIC2 HPE cases suggest a 
laterality defect 
 
Extra-craniofacial defects, including cardiovascular, visceral and urino-genital 
anomalies have previously been noted in patients with holoprosencephaly (HPE) carrying 
ZIC2 mutations2,3, but the details of these malformations have not previously been 
documented. We examined clinical reports derived from a previously published European 
series consisting of 645 HPE probands3, including both liveborns and medically terminated 
pregnancies.  A total of 67 probands in this series have ZIC2 mutation, of which 8 (12%) 
exhibit cardiovascular or visceral anomalies suggesting a putative laterality defect (Table 1). 
The affected probands have mutations including three single amino acid substitutions 
(p.(His156Tyr); p.(Gln36Pro); p.(Phe314Cys); all affect highly conserved residues and are 
not found in 61,000 control exomes from the ExAC Project), alanine tract deletions and 
duplications, and larger chromosomal aberrations (Table 1; Fig S1a, b). 
 
Proband 7 has the most severe alobar form of HPE and also exhibits the most 
pronounced laterality defect (Table 1). This proband exhibits a loss of normal asymmetric 
thoracic anatomy, indicated by a duplicated superior vena cava (SVC) and a bilobulated 
lung.  The right and left brachiocephalic veins are normally fused in man to form a single 
SVC which enters only the right atrium. Duplicated SVC therefore indicates bilateral 
connection to both atria, indicative of the laterality defect right atrial isomerism. Pulmonary 
morphology is also normally asymmetric in man such that, while the right lung has three 
lobes the left has only two. This patient has a symmetrical bilateral left-sided anatomy, 
suggesting left pulmonary isomerism. Thus, there is discordance between cardiovascular 
and pulmonary situs indicating situs ambiguus, a common phenomenon in heterotaxy. 
 
Proband 4 also has abnormal lung lobulation indicating a laterality defect, but 
unfortunately the attending clinician did not record the details of this malformation and we 
are unable to assign situs. The same proband has additional features indicative of a laterality 
defect including a single umbilical artery (also seen in Probands 2 and 5) and a common 
mesentery. Proband 1 has spleen hypoplasia suggestive of right isomerism (which is also 
known as asplenia). This proband also has both adrenal and renal hypoplasia, features 
suggestive of abnormal abdominal situs. Pulmonary hypoplasia in this proband may indicate 
abnormal pulmonary situs. 
 
Ventricular septal defect (VSD) is the most common cardiovascular anomaly 
observed (5 of 67 ZIC2 probands). This is associated with hypoplastic ascending aorta in 
two probands, while another exhibits Tetralogy of Fallot. VSD is frequent in mouse models 
with a laterality defect32 but is not diagnostic because it is also commonly associated with 
other genetic conditions, such as Chromosome 22 deletions33,34. 
 
In summary, this analysis indicates that HPE is seen in ZIC2 probands together with 
cardiovascular, pulmonary and visceral malformations suggestive of an underlying laterality 
defect. 
 
Identification of the Zic2 iso mutant 
 
We performed a recessive ENU mouse mutagenesis screen in which MRI screening was 
used to identify novel mutants exhibiting cardiovascular anomalies at E14.5 35,36. This 
resulted in isolation of the iso (isomeric) line.  Mapping and sequencing revealed a stop-gain 
mutation (Y401X) in the Zic2 gene disrupting the fifth zinc finger domain of the protein 
(Figure.S2; Table S1).  The phenotype was validated through generation of a series of 
additional alleles, each with mutation targeted to the fifth zinc finger domain using TALEN-
based gene editing31. Line Zic2A8 encodes an identical protein to iso (Y401X), while Zic2A5, 
Zic2A10, Zic2A17 and Zic2A19 have short DNA deletions leading to a frameshift followed by 
premature termination (Zic2A5 , Zic2A10, Zic2A17) or an internal deletion (Zic2A19). All mutations 
affect the fifth zinc finger domain (Figure S2) and thus differ from the previously published 
Zic2ku mutant in which the fourth zinc finger is disrupted (C370S)37.  iso fails to complement 
either Zic2A8 or Zic2A5 (Table 2).  
 
Zic2 mutants exhibit holoprosencephaly 
 
External examination revealed that all Zic2 mutant embryos (n=37) had neural tube defects 
including exencephaly, spina bifida and curly tail (Table 2; Figure 1; Figure 2a, b); spina 
bifida was also present in 2/27 heterozygotes, which also frequently show curly tail 
(Figure.S3; 31), while wild-type embryos (n=22) had no anomalies.  We employed µCT and 
MRI imaging to analyse the phenotype more closely.  All embryos examined had 
holoprosencephaly (Table 2; Figure 1). A range of severity was seen, but the majority of 
embryos had the most severe alobar form in which the two hemispheres are completely 
fused (27 of 33; Figure 1 b2). The remaining 6 had the semilobar form, indicating partial 
hemisphere fusion. No embryos were observed to have the mild lobar form of HPE.  Six of 
33 embryos lacked eyes, cyclopia was seen in 17 of 33 embryos (Figure 1 b3).  and 
hypotelorism in 10 of 33. These neural tube phenotypes are consistent with those of the 
previously described Zic2Ku mutant 4,37, suggesting that Zic2iso may also carry a loss of 
function mutation. 
 
Zic2iso mutants have extensive cardiovascular, thoracic and abdominal malformations  
 
CT imaging also revealed extensive defects within the cardiovascular system, thorax and 
abdomen of Zic2iso and TALEN mutants (Figure 2; Table 2), many of which have not been 
previously described for Zic2.  
 
We observed severe cardiovascular malformations in the majority of embryos. Abnormal 
ventricular topology was seen in half of all embryos examined (16 of 32; Table 2) such that 
the morphologically right ventricle was positioned on the left side of the embryo (Figure 
2c,d), while it was normal in the other 16. This 50-50 split indicates that the direction of heart 
tube looping was randomly assigned in these embryos, consistent with the phenotype 
previously described in younger Zic2Ku embryos24. The majority of embryos had an ostium 
primum atrial or atrio-ventricular septal defect (19 of 30; Figure 2 e,f asterisk).  21 of 35 
embryos exhibited bilateral systemic venous sinuses (Figure 2 e-h), often with bilateral right-
sided atrial appendages. Double outlet right ventricle was seen in 14 of 32 embryos 
examined (Figure 2 c,d ) and ventricular septal defect was present in 23 of 33 embryos 
(Figure 2c,d ).   Defects were observed in the vascular system at reduced penetrance 
relative to the cardiac defects, and were generally present in about a third of embryos.  The 
inferior vena cava (IVC) was found to be aberrantly left-sided in 11 of 36 embryos (Figure 2 
g-j ), while 8 of 36 exhibited hepatic vein drainage directly into the atrium, bypassing the IVC 
(Figure 2 g,h ).   A right-sided aortic arch was observed in 11 of 37 embryos (Figure 2 k,l ).    
 
In mouse, the right lung is divided into four distinct lobes while the left consists of a 
single lobe (Figure 2 m). We observed bilateral multilobed lungs in 27 of 37 mutant embryos 
(Figure 1 b4; Figure 2 n), while a single embryo was observed with a 1:1 lobed 
arrangement (Table 2).  All control and heterozygous embryos showed a normal 4:1 lobed 
arrangement. The stomach and pancreas are normally located on the left side of the body 
but were observed to be ectopically right sided in 11 of 37 and 7 of 28 mutant embryos 
respectively (Figure 2 p; Table 2).  The spleen was reduced or absent in 5 of 16 embryos 
and right-sided in another two (Table 2). 
 
Zic2iso mutants have right isomerism 
 
A random distribution in the direction of looping of the heart tube and gut among mutant 
embryos is indicative of a generic laterality defect, but does not provide information on the 
specific situs of affected individuals. This may be assigned based on careful examination of 
the anatomy of the lungs and atria, the positioning of visceral organs and the organisation of 
the vascular system, all of which show precise phenotypes that may be classified as right-
isomerism, left-isomerism or situs inversus 17,38.  
  
Pulmonary anatomy is a useful indicator of thoracic situs because the lungs have a 
lateralised morphology determined by Pitx2c expression.  Bilateral multi-lobed lungs are 
indicative of a lack of Pitx2c expression (right isomerism) while bilateral unilobar lungs 
indicate bilateral Pitx2c expression (left isomerism).  Situs inversus, in contrast (right-sided 
Pitx2c expression), would be expected to result in a four-lobed lung on the left side and a 
single lobed lung on the right.  Our data indicate that 73% of Zic2 embryos (27/37) exhibit 
right pulmonary isomerism, 3% (1/37) exhibit left isomerism, 24% (9/37) have the normal 
anatomy (situs solitus) and no embryos have reversed situs.  This distribution is significantly 
different from a random distribution of the four phenotypes, and reveals a strong bias 
towards the phenotype of right isomerism (Chi squared test, p=5.7 x 10-11). Similarly, 
bilateral systemic venous sinus and bilateral right atrial appendage is indicative of right atrial 
isomerism. We observe bilateral systemic venous sinus (right atrial isomerism) in 60% of 
embryos (21/35), with no evidence for left isomerism or reversed situs. This distribution is 
also significantly different from a random distribution (Chi squared test, p=3.1 x 10-8).  
Double outlet right ventricle (44%; 14/32) is associated with right but not with left 
isomerism32,39. Abnormal right-sided aortic arch looping is not seen in left isomerism40 but is 
present in right isomerism32,41 and in situs inversus. We did not observe vascular phenotypes 
associated with left isomerism such as interruption of the inferior vena cava and partial 
anomalous pulmonary return17. Asplenia is commonly associated with right isomerism 42, 
and indeed the human disease is sometimes known as Asplenia. The spleen is reduced in 
mice lacking the NODAL receptor Acvr2b, although asplenia seems to be observed only in 
Cfc1 (Cryptic) mutants41,43. We observe reduced or right-sided spleen in 44% of embryos 
(7/16) while none exhibited polysplenia, a feature of left isomerism.  
 
These data thus indicate a strong bias towards right isomerism.  Only one embryo exhibits 
any feature of left isomerism (bilateral unilobed lungs) and this embryo does not show atrial 
left-isomerism nor any vascular phenotype associated with left-isomerism.  
 
The NODAL pathway is downregulated in Zic2 mutants 
 
We performed a microarray experiment in mice as an unbiased screen to identify putative 
Zic2 transcriptional targets.  Global gene expression was assayed in whole Zic2iso/iso 
embryos harvested at E8.0 -E8.5 (0-4 somites) relative to wild-type. Only 29 genes showed 
a significant change in their expression level (with a false discovery rate of 5%) and the 
majority (23/29) were downregulated (Fig. 3a, b; Table S2). Some of these, such as Dmrt3 
and Fzd5, are specifically expressed in the developing head. Other downregulated genes 
have an established role in left-right patterning including Lefty2 (-5.1), Nodal (-2.5), Lefty1 (-
1.8) and Shh (-2.0).  Downregulated genes also include Gdf10 (-2.01) and Chordin (-1.53), 
which are, like Nodal and Lefty, associated with TGFβ signalling, and Sox9 which has not so 
far been associated with LR establishment in the mouse although it is known to be involved 
in sea urchin44.  Many of the changed genes, including Nodal, Shh, Fam183b, Foxd4 and 
Dynlrb2 are known to be expressed within the node, while others including Gsc and Lefty1 
are expressed in node-derived cells at the midline. Upregulated genes included the 
pluripotency factor Nanog (+1.67). To validate these changes we performed quantitative 
real-time polymerase chain reaction (qPCR) assays for changed genes, as well as for the 
NODAL pathway genes Pitx2c and Dand5 (also known as Cerl2; Fig. 3c). This analysis 
confirmed the downregulation of Nodal, Lefty2, Lefty1 and Shh. Surprisingly, Pitx2c was not 
changed. We hypothesised that this might be because the assay was performed at an age 
before Pitx2c is upregulated in the LPM, and therefore repeated the analysis using older 
embryos.  In older embryos (aged 4-6 somites), we observed a significant reduction in 
expression, which persists in embryos of 12-25 somites (Fig. 3d), indicating that Pitx2c is 
downregulated in the iso embryo during the time at which it is normally expressed in the 
LPM. Thus, these data suggest downregulation of the NODAL pathway in the iso embryo. 
 
Zic2 is required for Nodal expression in perinodal crown cells 
 
We used in situ hybridisation to further analyse changes in the core NODAL pathway genes.  
Pitx2 expression was investigated using a probe which recognises all three Pitx2 isoforms45 
and was found to be expressed in the head folds and in the LPM in the wildtype embryo (Fig 
4a). In Zic2iso/iso embryos Pitx2 expression was seen in the head folds, but was weak or, in 
many cases, absent from the LPM (Fig 4b, arrow). Expression appeared to be delayed from 
the 4 to the 6-somite stage, it was weaker, and its laterality was perturbed, often bilateral 
(Fig 4c). Lefty2 was expressed exclusively in the left LPM of wildtype embryos aged 
between 4 to 6 somites (Fig 4d, e). All Zic2iso/iso embryos failed to express Lefty2 (Fig 4f-h).  
Nodal was expressed in the node of all wildtype embryos examined (Fig4i, arrowhead) and 
was either bilaterally expressed or was enriched on the left side of the node (Fig 4m ). In the 
LPM, Nodal was expressed in all wildtype embryos from 2 to 6 somites and was restricted to 
the left side (Fig4 i, arrow; Fig 4n). Nodal expression at the node of Zic2iso/iso embryos was 
in most cases (7 of 8) weak or absent (Fig 4j-m). Expression was only detectable in early 
somite stages (1 to 4 somites) mutant embryos (5 of 8), and its abnormal laterality in one of 
them suggested a defective nodal flow, which would be consistent with the requirement for 
Zic2 in node cilia development or function as previously proposed24. Most Zic2iso/iso embryos 
(6 of 8) failed to express Nodal in the left LPM (Fig. 4j, n). In the two mutant embryos that 
did express Nodal in the LPM, it was weak and was observed in both left (Fig 4k) and right 
LPM (Fig 4l). Cerl2 (Dand5), known to be the earliest asymmetrically biased gene 
expressed at the node, (L<R)46 was expressed exclusively within the node of wildtype 
embryos (Fig 4o, p) and was observed to be enriched on the right side of the node in 8 of 9 
embryos (Fig4 s). Cerl2 appeared to be maintained at wildtype levels in Zic2iso/iso embryos 
(Fig 4q-s), but the onset of its laterality appeared to be delayed and slightly perturbed (Fig 
4s), an observation again consistent with the possibility that the mutation of Zic2 initially 
results in defective nodal flow and randomisation of gene expression at the node. We also 
studied the expression of Shh, which was detected along the embryonic midline in wildtype 
embryos in a solid band (Fig 4t). In Zic2iso/iso embryos, expression levels were maintained 
but there seemed to be fewer positive cells and the band of expression appeared disrupted 
(Fig 4u) suggestive of impaired development of Shh-expressing cells in these embryos. 
 
In summary, we find some anomalies suggestive of an occasional randomisation of LPM 
identity (bilateral Pitx2c expression, right-sided expression of Nodal). These anomalies 
match the laterality defects we characterized in the expression of Nodal and Cerl2 at the 
node, defects which are consistent with the Zic2 mutation leading to nodal flow 
perturbations, most likely as a result from the node cilia defect described in Zic2Ku 24. 
However, our data show that the predominant phenotype is the absence of expression in the 
LPM. This failure to activate NODAL-dependent gene expression (Nodal, Pitx2c, Lefty2) in 
the LPM is consistent with the later bias towards right-isomerism revealed by our analysis of 
the Zic2iso mutant phenotype. Nodal expression within the node, a prerequisite for 
downstream gene expression in the LPM13,46, is reduced or absent in most embryos. These 
data suggest that ZIC2 may be required for Nodal expression at the node. 
 
ZIC2 binds to the Nodal locus and can activate transcription 
 
The expression of Zic2 in the epiblast overlaps with that of Nodal from the blastocyst stage 
to the late gastrula stage, up to and including formation of the node6,7. The dynamic 
expression of Nodal during development is regulated by five enhancers 47-49.  Analysis of 
previously published ChIP-seq datasets26,27 shows that ZIC2 is bound to the Nodal locus in 
both ESCs and in EpiSCs (Fig 5a). In ESCs, prominent binding peaks were mapped to the 
Proximal Epiblast Enhancer (PEE)50 and to the Highly Bound Element (HBE)49 (Fig 5a, 
green dots). These binding sites are also occupied in EpiSCs, but two additional high-affinity 
binding peaks are seen within the Node Dependent Enhancer (NDE)51 and in HBE (Fig 5a, 
red dots) indicating that ZIC2 binding is more widespread in these cells. Further low-affinity 
peaks map to the Asymmetric Enhancer (ASE)48,51, to Exon 1 and to HBE (blue dot).  
 
We tested the ability of ZIC2 to regulate the transcriptional activity of each of the five Nodal 
enhancers using luciferase reporter constructs in which the enhancer is linked to the minimal 
E1b promoter49 (Fig 5b). Each construct was co-transfected in U2-OS cells together with an 
expression plasmid encoding ZIC2 or an empty vector (pcDNA).  
 
The ASE enhancer showed a strong basal activity in control cells suggesting activation by 
endogenous factors present in U2-OS cells (Fig 5b). For this reason, we were not able to 
accurately test the ability of ZIC2 to activate this enhancer. Low basal activity was observed 
for the remaining enhancers. We found no evidence for ZIC2-mediated transcriptional 
activation from the PEE, NDE or AIE enhancers. HBE, in contrast, shows a robust ZIC2-
mediated transcriptional activation. HBE has been shown to be transcriptionally active in 
primitive streak-like cells (node precursors) 49.  
 
Zic3 has a phenotype closely resembling that of Zic2, including laterality-related 
malformations and HPE52,53, and also exhibits reduced or absent expression of Nodal52.   
ZIC3 has previously been shown to be able to activate an NDE enhancer 54. We therefore 
asked whether ZIC3 can also activate expression from the HBE enhancer. Luciferase 
assays demonstrate that ZIC3 activates HBE at a level similar to that of ZIC2 (Fig 5c), 
lending further support to the hypothesis that this enhancer may be important in LR 
patterning.  
 
We next asked whether the iso mutation reduces the ability of ZIC2 to activate the HBE 
enhancer, and thus whether a failure to activate Nodal might explain the phenotype. The 
Zic2 kumba allele has been shown to evade nonsense mediated decay (NMD) but to 
produce a protein which cannot activate the ApoE promoter in luciferase assays55. While the 
kumba mutation disrupts a cysteine residue in the fourth zinc finger37, the iso mouse carries 
a Y401X mutation which disrupts the fifth zinc finger of ZIC2 (Fig S1). Two lines of evidence 
indicate that iso, like kumba, may evade NMD. Firstly, Zic2 mRNA is not significantly 
reduced in iso embryos by microarray analysis (Table S2). Secondly, qRT-PCR analysis 
indicates that the mRNA can be detected in mutant embryos (Fig S4). We used site-directed 
mutagenesis to generate a Y401X mutation within the ZIC2 expression construct (named 
ZIC2-ISO) and tested the response of the HBE luciferase reporter to this. ZIC2-ISO shows a 
reduced ability to activate HBE (Fig 5c), just above the threshold of significance (p=0.09), 
but still maintains some transcriptional activity. This, together with potential redundancy with 
ZIC3, may explain the partial penetrance of the Zic2iso phenotype. 
 
To gain further insights into the regulation of HBE by ZIC2, we investigated ZIC2 binding 
sites within HBE. ChIP-seq data suggests the presence of three putative binding sites, and 
we found that each of these contains sequence matching the consensus ZIC2 binding motif. 
ZIC2 Binding Site 1 (ZBS1) is located at position 99-109bp within HBE and has the 
sequence CACCTCCTGGG (Fig. 5a,d,e red dot), ZBS2 at position 615-625bp with 
sequence CCCCTGGGGTG (Fig 5a,d,e green dot), and ZBS3 at 1845-1855bp with 
sequence GCCCTCCTGGG  (Fig 5a,d,e blue dot). We used site-directed mutagenesis to 
delete each of these sites within the HBE-luciferase reporter construct. Luciferase assays 
indicated that while deletion of sites ZBS1 and ZBS2 has no effect on ZIC2-mediated 
transcriptional activation, reporters lacking ZBS3 completely lost their responsiveness to 
ZIC2, indicating that an intact site ZBS3 is an absolute requirement (Fig 5d). 
 
An electrophoretic mobility shift assay (EMSA) confirmed binding of ZIC2 to ZBS2 (occupied 
in 
both ESCs and EpiSCs) and ZBS3 (required for activation but demonstrating only low-affinity 
binding in ESCs and EpiSCs) but not to ZBS1 (occupied in EpiSCs but not in ESCs) in vitro 
(Fig 5e). 
 
Thus, these data demonstrate that the HBE enhancer, which is bound by ZIC2, both in vivo 
in node precursors (Fig 5a) and in vitro (Fig 5e), can mediate ZIC2-dependent and ZIC3-
dependent transcriptional activation in vitro (Fig 5b, c). An identified ZIC2 site within HBE, 
bound at low-affinity in precursor cells (Fig 5a) is required for this activity in vitro (Fig 5d) 
and a ZIC2 mutation reproducing the iso mouse mutant, which has impaired Nodal node 
expression (Fig 4j-m), can reduce the ability of ZIC2 to activate HBE (Fig 5c). 
 
DISCUSSION 
 
In this work, we reveal that ZIC2/Zic2 loss in both man and mouse is associated with a 
complex set of previously unappreciated malformations affecting the cardiovascular, 
pulmonary and digestive systems, in addition to the better known neural tube defects. The 
mouse phenotype reveals a laterality defect which shows a strong bias towards right-
isomerism, indicative of a lack of left-sided identity in the lateral plate mesoderm during 
morphogenesis of these organ systems.  This is supported by molecular data indicating that 
the left-determining NODAL signalling cascade fails to be activated in the LPM. Nodal 
expression at the node is also impaired, implying that ZIC2 acts upstream of this event. 
Binding of ZIC2 to the Nodal locus in EpiSCs, together with in vitro data revealing ZIC2-
mediated transcriptional activation of regulatory sequences, suggests that a direct interaction 
between ZIC2 and Nodal is critical for the establishment of left-sided mesoderm identity.  
  
The association of Zic2 with cardiovascular laterality defects was first demonstrated in the 
Zic2Ku mouse, in which the direction of heart tube looping was shown to be randomly 
assigned 24. Node cilia were found to be reduced in length in these mutants from 4µm to 2.5 
µm, and this, together with the earlier observation that Zic2 expression in the node is turned 
off just before Nodal expression in perinodal cells is initiated 6, led to the conclusion that the 
laterality defect (interpreted as random cardiac situs) resulted from impaired nodal cilia 
development24. A randomised distribution in the direction of heart tube looping within a 
population of mutants does not in itself indicate randomised cardiac situs. Such a phenotype 
is also associated with specific, non-random laterality defects such as isomerism32,56. This is 
because, in the absence of laterality, heart looping lacks directionality and may turn in either 
direction. The Zic2Ku mutant exhibits mid-gestation lethality, preventing further investigation. 
In contrast, most Zic2iso and TALEN mutants survive until E15.5, which has allowed us to 
perform a more detailed analysis of the laterality phenotype. We confirmed the heart tube 
looping phenotype but revealed that this results not from randomisation of situs, but from 
right isomerism. Zic2iso and TALEN mutants show a strong bias towards right isomerism over 
other laterality phenotypes. Pulmonary situs was assessed in a total of 37 Zic2 mutant 
embryos, of these 73% showed right pulmonary isomerism, a single embryo exhibited left 
isomerism and none had situs inversus. The same phenotype was seen in multiple 
independent Zic2 alleles. Laterality of the cardiovascular system matched that of the thorax, 
albeit at reduced penetrance, as demonstrated, for example, in right atrial isomerism, which 
was seen in 60% of embryos. Many other features indicate right isomerism and not left 
isomerism or situs inversus. 
 
This conclusion is consistent with the observed molecular phenotype. Both Zic2Ku and Zic2iso 
mutants fail to activate NODAL signalling in the LPM. Zic2Ku mutants lack Nodal and Lefty2 
LPM expression, and have reduced Pitx2 expression24. Our analysis reveals a similar 
molecular phenotype in the Zic2iso mutant.  Mutations which impair the motility of node cilia 
such as the iv mutant of the cilia dynein Dnah112, or mutations in transcription factors 
required for cilia development such as Noto 57, result in the stochastic activation of NODAL 
signalling in the LPM. This is visualised via detection of the expression of 
Nodal/Pitx2c/Lefty2 with the same frequency on the left, on the right, on both sides or in 
none, and leads at later stages to equal proportions of embryos with situs solitus, situs 
inversus, right isomerism or left isomerism. Only 4 out of 20 E8.5 Zic2iso mutant embryos 
examined showed ectopic expression of these genes in the LPM. 15 failed entirely to 
express them in this tissue, an observation consistent with the fact that 73% of those 
examined at E14.5 exhibited right isomerism. These numbers do not support the hypothesis 
that a defect in cilia motility is the major cause of the laterality defect.  
 
Although there is ample evidence that cilia motility conditions the asymmetry of Nodal 
expression in perinodal cells, this asymmetry in mRNA expression is not itself required to 
induce Nodal expression in the left LPM 47,58,59. What appears to matter is the amount of 
NODAL protein produced. Pioneering studies relying on the removal of specific Nodal 
enhancers have established that Nodal expression at the node is required to induce Nodal 
expression in the LPM13, 58, 59thus providing an explanation for the right isomerism of Zic2 
mutant embryos that fail to express Nodal at the node. However these studies also showed 
that residual Nodal expression at the node could be sufficient to induce correct expression in 
the LPM, and therefore call into question whether the low level of Nodal we detect at the 
node in some of our Zic2 mutants is the only reason for their failure to induce NODAL 
downstream targets in the LPM. Assessing the exact contribution of the loss of Nodal 
expression at the node to the observed phenotype would require a rescue experiment in 
which a transgenic construct is used to drive Nodal expression at the node in a Zic2iso 
mutant background.  
 
The situation is arguably complex in these mutants, because Nodal may not be the only 
gene in the pathway regulated by ZIC2. The level of Nodal expression in the node required 
to induce its own expression in the LPM may thus be different, and perhaps higher, than that 
in wildtype embryos, to compensate for a possible concomitant down-regulation of partners 
or agonists. Gdf1, encoding a co-ligand of NODAL, is likewise expressed in perinodal cells 
where it is required to ensure the adequate transfer of NODAL to the LPM60, and could be 
one such partner as its absence from the node also leads to right isomerism. No ZIC2-
binding peaks are present at the Gdf1 locus 26,27and our microarray analyses of Zic2iso 
mutant embryos detected no alteration of Gdf1 expression (Table S2), but, given that Gdf1 
is also bilaterally expressed in lateral plate mesoderm at this stage, this experiment may not 
be sensitive enough to detect its specific misregulation in perinodal cells. Interestingly, the 
expression of Gdf1 in these cells, like that of Nodal and Cerl2, is known to be dependent on 
NOTCH signalling61 Our observation that in most Zic2iso mutant embryos Cerl2 shows normal 
levels of expression in the node indicates that NOTCH signalling is likely to be intact in these 
mutants. This, together with a previous report that absence of Nodal expression in the node 
does not affect the expression of Gdf1 there58make it quite possible that its expression is 
similarly unaffected in the node of Zic2iso mutant embryos. However, further investigations 
are necessary to make certain that this is case, not just for Gdf1 but also for all the genes 
expressed at the node that contribute to the production and propagation of the left identity-
inducing signal.   
 
The occurrence of right isomerism has been described in embryos carrying point mutations 
in either Pkd1l1 or Pkd2, which are believed to affect the detection of nodal flow by immotile 
cilia62, rather than affecting motile cilia function (node morphology and cilia motility is 
unaffected in these mutants). Crucially, not only does the NODAL signalling cascade fail to 
be activated in the LPM of these mutants, both Nodal and Cerl2 expression at the node 
remain symmetrical, unlike in Zic2 mutants. Pkd1l1 and Pkd2 expression is restricted to the 
node at E7.0-E7.75. Our microarray data shows no evidence for a downregulation of their 
transcripts in the Zic2iso mutants, but in situ data suggests they may be reduced in Zic2Ku 24 
mutants. The anomalies we detected in the laterality of Nodal and Cerl2 expression around 
the node of Zic2iso mutant embryos confirmed that their nodal flow is perturbed, and suggest 
that motile cilia at the node present defects similar to those characterized in Zic2Ku mutants24. 
However, the emergence of these anomalies, and their occasional consistency with 
corresponding anomalies in the expression of Nodal or Pitx2 in the LPM, suggest immotile 
cilia are functional and argue against this mutant version of ZIC2 having a major impact 
downstream of the nodal flow.  
 
The expression of Cerl2 in perinodal cells of Zic2iso mutant embryos indicates NOTCH 
signalling is intact. This suggests that the Nodal locus in this mutant is either unresponsive to 
NOTCH signalling or unable to maintain its own expression after it is induced. The dynamic 
expression of Nodal is regulated by five distinct enhancers, three of which (NDE, PEE and 
HBE) were found to harbour significant ZIC2-binding peaks in ESCs and/or in EpiSCs (Fig 
5a). NDE is active in perinodal cells and its deletion eliminates most, but not all, of Nodal 
expression at the node. Its transcriptional activity has been shown to be dependent on 
NOTCH signalling59 and a previous study using Xenopus cells, has shown that it can be 
activated by ZIC354, a transcription factor closely related to ZIC2. NDE therefore would 
appears as an ideal candidate to mediate the influence of ZIC2 on Nodal expression at the 
node, however we did not detect an effect of ZIC2 on its transcriptional activity in our 
luciferase assay and further analysis will be necessary to find out whether it does mediate 
this influence in vivo.  
 
PEE transcriptional activity is detected in the proximal epiblast and in the anterior primitive 
streak, but not in the node50. Deletion of PEE has been shown to result in a range of defects, 
including heart abnormalities50, which are reminiscent of those of Zic2 mutants. However, 
like for NDE, we did not detect an effect of ZIC2 on the transcriptional activity of PEE in our 
luciferase assay. These data leave open the possibility that this enhancer mediates the 
influence of ZIC2 on a domain of Nodal expression that is critical for anterior patterning and 
the establishment of laterality, but again further analysis will be necessary to confirm this is 
the case. 
  
 
HBE was the only Nodal enhancer showing a ZIC2-mediated transcriptional activation 
response. Mutagenesis analysis indicated both that a defined ZIC2-binding site within HBE, 
ZBS3, is required for this response, and that a protein carrying the same mutation as the iso 
mouse shows a reduced ability to activate HBE. While the transcriptional activity of HBE is 
highest at preimplantation stages it is still detectable in the post-implantation epiblast, in the 
primitive streak and in the early node49. The impact on embryonic development of its deletion 
at these stages is not yet known, but these data suggest that an interaction between ZIC2 
and HBE may be required for Nodal to be correctly expressed at the node. Testing this 
hypothesis calls for an investigation of the impact of a targeted mutation of ZBS3 on Nodal 
expression and the establishment of laterality. 
 
Our analyses indicate that ZBS3 is a low-affinity ZIC2-binding site, and that higher affinity 
ZIC2-binding sites in HBE are dispensable for its transcriptional activity. This is consistent 
with current models of how transcription factors regulate gene expression, which place 
greater emphasis on the critical role played by low-affinity binding sites63. This result led us 
to consider the possibility that another Nodal enhancer, ASE, in which a low-affinity ZIC2-
binding site similar to ZBS3 was identified in EpiSCs, might also mediate the influence of 
ZIC2 on Nodal expression at the node. ASE is an auto-regulatory enhancer, known to be 
dependent on Activin/Nodal signalling. Mouse embryos deleted for ASE show very weak 
Nodal expression in the left LPM, which leads to partial right isomerism later on47. Crucially, 
the level of Nodal expression at the node at E7.5 and E8.5 in these mutants is similar to that 
of wildtype embryos, except that it remains symmetrical. This observation appears to rule out 
the possibility that ASE plays a critical role in mediating the influence of ZIC2 on Nodal node 
expression. 
  
Thus, a review of the evidence relating to NDE, PEE and HBE leaves open the possibility 
that they may all be, directly or indirectly, involved in promoting the influence of ZIC2 on the 
expression of Nodal during the time window in which ZIC2 function at the midline is critical 
for the establishment of a left identity in the LPM, which broadly extends from E6.5 to E7.5. 
The expression of Zic2 and the transcriptional activity of NDE only overlap briefly in the 
young node, which seems to preclude a prolonged interaction. In contrast, the overlap with 
the transcriptional activities of HBE and PEE in the epiblast and in the primitive streak, 
ahead of node formation, is extensive. This may be important as ZIC2 has been shown to 
act as a pioneer factor in ESCs, binding to target genes before they are transcriptionally 
active, seeding the locus to facilitate binding of additional factors later in more differentiated 
cell types26,29. Furthermore, in the case of Nodal, the presence of one of the ZIC2-bound 
enhancers, HBE, has been shown to condition the later activation of at least one of the other 
Nodal enhancers27. These observations may explain how the impact of ZIC2 absence on 
Nodal node expression could be delayed until a time when the transcription factor is no 
longer expressed. ZIC2 associates at a subset of loci in ESCs with the NURD chromatin 
remodelling complex27, a complex known to regulate bivalent enhancers. ZIC2 is bound to 
the Nodal locus in epiblast stem cells, precursors of the node, and is able to activate 
expression in in vitro assays from one such bound enhancer (HBE), yet there is no obvious 
phenotype at this stage of development in Zic2 mutants. All available data is therefore 
compatible with the possibility that ZIC2 interaction with regulatory sequences at the Nodal 
locus in node cell precursors in the primitive streak primes it for later activation, a pre-
requisite for the correct establishment of left-sided identity. Further work will be required to 
test this hypothesis and to elucidate the precise molecular mechanisms by which ZIC2 may 
regulate Nodal expression. 
 
Our analysis lends support to the hypothesis that cardiovascular and other visceral defects 
seen in ZIC2 HPE patients may result from an underlying laterality defect. However, it would 
appear that the co-morbidity of cardiovascular laterality defects with HPE is a relatively rare 
event in reported ZIC2 HPE cases, occurring in only between 9 and 14% of cases2,3. 
Cardiovascular malformations of this kind are embryonic lethal in mice and thus many 
pregnancies may be lost before term, indeed only one of the probands we describe was born 
alive. Thus, many cases may go unreported. It should also be noted that most patients have 
heterozygous ZIC2 mutation; heterozygosity in mice is associated with mild neural tube 
defects but is not associated with cardiovascular malformations. Thus, milder forms of HPE 
reported in living patients would not be expected to be associated with cardiovascular 
anomalies.  Situs abnormalities do not always manifest in right isomerism in human cases as 
in the mouse model, and we find evidence for discordance between cardiac and pulmonary 
situs suggesting heterotaxy in one patient. This is likely to be for a number of reasons. The 
patient with heterotaxy (Proband 7) carries a large chromosomal deletion encompassing 
many genes in addition to ZIC2 and therefore genetic interactions are likely to be a factor. 
Genetic background is known to affect the penetrance of cardiovascular laterality 
phenotypes32, indicating that genetic interactions at multiple loci influence the phenotype. 
This may also reflect the influence of environmental factors, which are known to impact upon 
the expression of cardiovascular phenotypes64. Finally, in many cases it is not possible to 
make a definitive diagnosis based on the information provided. 
 
Our data nevertheless explain the co-morbidity of holoprosencephaly with congenital heart 
disease and suggest that ZIC2 should be considered as a candidate for screening for the 
latter disease. 
  
 
METHODS 
Human genetics 
All protocols were approved by the local ethics committee of Rennes Hospital. All work was 
carried out in accordance with this protocol. All samples were obtained and analysed with 
informed consent according to the protocols approved by the local ethics committee (Rennes 
Hospital). 
 
Mouse genetics 
All animal procedures were approved by the Committee for Animal Care and Ethical Review 
at the University of Oxford, and all the experiments conformed to the UK Animals (Scientific 
Procedures) Act, 1986, incorporating Directive 2010/63/EU of the European Parliament. All 
animal procedures were performed in accordance with UK Home Office regulations (PPL 
30/3174). The iso allele was isolated in a random recessive ENU mutagenesis screen in 
which cardiovascular anomalies were identified by MRI screening of E14.5 embryos 35,36.  
Male C57Bl6/J males were mutagenized then crossed to C3H/HeH females. G3 progeny 
were screened for a phenotype. TALEN alleles of Zic2 have been previously described 31. All 
Zic2 alleles were subsequently backcrossed for several generations and then maintained on 
a C3H/HeH background (mice obtained from MRC Harwell, Oxfordshire, UK) and embryos 
of both sexes were used in experiments. Heterozygous animals were crossed and pregnant 
dams were sacrificed by cervical dislocation before the embryos were dissected and 
processed for further analyses. Genotyping was performed using allele-specific Taqman 
probes on DNA obtained from ear biopsies. In all experiments, mutant embryos were 
compared to littermate controls. 
 
Genetic mapping and sequencing.  
Mutations were mapped using a panel of SNP markers that differentiate between C57BL6/J 
and C3H/HeH mouse strains, as described previously  35, identifying a minimal homozygous 
segregating interval lying on chromosome 14 between SNP rs13482392 (118.9 Mb) and the 
end of the chromosome at 124Mb. The identified chromosomal interval was then exome 
sequenced using SureSelectXT mouse all exon kit (Agilent, as recommended by the 
manufacturer).  Captured libraries were sequenced on the Illumina platform as paired-end 
76-bp reads. Study accession number ERP000530.  The only exonic mutation identified 
within this interval was a C to A substitution at position 122877892 indicating a stop-gain 
mutation (Y401X) in the Zic2 gene disrupting the fifth zinc finger domain (Fig.S1; Table S1). 
This was confirmed by capillary sequencing.  No other exonic mutations were identified 
within the mapped interval. 
 
Phenotyping by MRI/µCT scanning 
Embryos were harvested at either E14.5 or E15.5, exsanguinated in warm HANKS saline 
(SIGMA, H4641), cooled down in ice cold PBS and then fixed in 4% paraformaldehyde.  
Imaging was performed using either MRI (Iso, A8, A10/17, A19) or by µCT (A5). MRI was 
performed as previously reported 65. µCT was performed using SkyScan 1172 scanner 
(Kontich, Belgium). Prior to scanning, embryos were incubated in 0.025N Lugol’s solution for 
4 days to achieve soft tissue contrast and embedded in a tube with 1% agarose.  Generated 
datasets were analysed and 3D reconstructions generated using Amira 5.3.3 software (FEI 
Visualization Sciences Group, Merignac, France). 
 
Microarray analysis 
E8.5 wildtype and Zic2iso/iso whole embryos were collected and snap frozen in liquid nitrogen.  
Eight stage-matched embryos were pooled per sample and three replicates of each 
genotype were performed.  RNA was prepared using the RNeasy Plus Micro kit (Qiagen) 
and hybridised to Illumina Mouse WG6 v2 arrays at Oxford Genomics Centre (following 
manufacturers’ protocol). Raw data were imported into R statistical software for processing 
and analysis (http://www.R-project.org). Pre-processing and normalisation steps were 
performed with the BioConductor 66 package ‘Variance Stabilisation and Normalisation’ 
(VSN) 67. Quality control analyses showed the data were high quality with no outlier samples. 
Statistical analysis was performed on the full dataset (approximately 45,000 probes) with the 
Linear Models for Microarray Analysis (LIMMA) package  68. Raw p-values were corrected 
for multiple testing using the false discovery rate (FDR) controlling procedure 69. At 5% FDR, 
this resulted in 30 significantly changed genes. A heatmap was generated using the 
Expander programme 70.  Microarray data has been submitted to the Gene Expression 
Omnibus (accession number will be provided following acceptance) 
 
qPCR 
Total RNA was harvested from whole embryos as above.  RNA was reverse transcribed 
using the Quantitect reverse transcription kit with genomic DNA eliminator (Qiagen), and 
analysed by SYBR Green based qPCR (Fig 2c; Supplementary Table 3 lists primers used) 
or using Taqman probes (Fig 2d, Fig S4) .  Graphs show the mean +/- standard deviation for 
three biological replicates, each consisting of a pool of embryos. A one tailed t-test was 
performed on linear expression values normalised to GAPDH to test the hypothesis that 
expression of selected genes is reduced in the mutant relative to wildtype. 
 
In situ hybridisation 
Embryos were harvested at E8.5 and fixed in 4% paraformaldehyde, 0.2% glutaraldehyde 
for 3 hours at 4°C before being dehydrated and stored in methanol at -20°C until use.  Prior 
to hybridising, embryos were bleached in 6% H2O2 and digested for 6 minutes in 10µg/ml 
proteinase K. Hybridisation was performed with digoxigenin-labelled RNA probes (2µg/ml) at 
70°C following standard protocols 71. Probes used are listed in Supplementary Table 4. 
 
Chip-Seq analysis 
ChIP-seq data used in this paper are from published studies 26,27; GEO accession numbers 
GSE61188, GSE74636. Binding peaks were visualised using the Integrated Genome Viewer 
software 72.  
 
Luciferase assays 
All assays were performed with U2-OS cells (obtained from ATCC) grown in DMEM with 
10% FBS. Cells were tested and confirmed free of mycoplasma contamination. Luciferase 
reporters carrying Nodal enhancers linked to a viral E1b promoter have been previously 
described 49. Generation of Y401X ZIC2 and deletion of ZIC2 binding sites within HBE was 
performed by site directed mutagenesis (NEB) using primers listed in Supplemental Table 5. 
Cells were transfected using Fugene reagent (Promega) with either HA-ZIC2 (Zic2), HA-
ZIC3 (Zic3), Y401X ZIC2 (Zic2-iso) or an empty vector (pcDNA) along with a 5x excess of 
reporter plasmid.  A Renilla luciferase reporter was co-transfected to control for transfection 
efficiency. Cells were harvested after 48-72hrs and assayed using the Dual Luciferase 
Reporter assay system (Promega). Each data point represents the mean of three technical 
replicates performed during the same experiment, and each experiment was repeated three 
times, as shown on the graphs. Asterisks indicate results of a one tailed t-test of samples 
with unequal variance testing the null hypothesis either that transfection with ZIC2 does not 
result in a change in activation of a given reporter over transfection with pcDNA (Fig 5b, 5d) 
or that there is no difference between the two indicated conditions (Fig 5c). * p<0.05, NS = 
not significant. 
 
EMSA assays 
Crude protein extracts were derived from HEK293T cells (obtained from ATCC, tested for 
mycoplasma 
contamination) transfected with a Zic2-HA expression plasmid or a control pcDNA plasmid. 
Cells were 
lysed in a solution of 10mM HEPES pH7.9, 1.5mM MgCl2, 10mM KCl, 0.5mM DTT and 
nuclei pelleted 
by centrifugation. Nuclei were lysed in 20mM HEPES pH7.9, 25% glycerol, 0.42M NaCl, 
1.5mM MgCl2, 
0.2mM EDTA, 0.5mM DTT. Short 31bp double-stranded biotin labelled probes (listed in 
Supplemental Table 6) were synthesised and EMSA assays performed using the Lightshift 
Chemiluminescent EMSA kit (Life Technologies). Unlabelled oligos were used as 
competitors and a supershift was performed with a monoclonal αHA antibody (Covance 
#MMS-101R). 
 
Data availability 
The microarray datasets generated in the current study are available in the GEO repository, 
accession number GSE106350. Luciferase constructs and mouse alleles described in this 
work are available on request.  
 
ACKNOWLEDGMENTS 
We thank Dominic Norris, Hiroshi Hamada, and Jose Belo for sharing in situ probes, Jun 
Aruga for sharing expression plasmids and Aude Vernet and Victoria Thornton for MRI/µCT 
assistance.  This work was supported by the British Heart Foundation [RE/13/1/30181 to 
I.M.D, RG/10/17/28553 to S.B., CH/09/003/26631 to S.B., RM/13/3/30159 to S.B., 
RE/08/004 to J.E.S., FS/11/50/29038 to J.E.S ]; and the Wellcome Trust [083228 to S.B., 
090532/Z/09/Z to S.B., 077012/Z/05/Z to D.J.A.]. 
 
 
AUTHOR CONTRIBUTIONS 
IMD : designed experiments, performed experiments, analysed data, wrote paper. 
DS : performed experiments, analysed data 
LK : performed experiments, maintained mouse colony 
RP: maintained mouse colony 
CC: performed experiments 
CP: contributed luciferase reporter constructs 
HL: performed statistical analysis of microarray data 
CD: shared human genetics data (Table 1) 
VD: shared human genetics data (Table 1) 
JS: developed CT imaging technology used in Figs 1,2 
TMK: performed exome capture of iso allele (sup. Table 1) 
DJA: designed exome capture experiment (sup. Table 1) 
SDMB: designed ENU mutagenesis screen 
SM: shared human genetics data (Table 1) 
SO: shared human genetics data (Table 1) 
JC: wrote paper, contributed luciferase reporter constructs  
SB : designed experiments, obtained funding for study, wrote paper. 
 
 
COMPETING INTERESTS 
The authors have no competing interests as defined by Nature Research, or other interests 
that might be perceived to influence the results and/or discussion reported in this paper.
REFERENCES 
 
1 Brown, S. A. et al. Holoprosencephaly due to mutations in ZIC2, a homologue 
of Drosophila odd-paired. Nat Genet 20, 180-183, doi:10.1038/2484 (1998). 
2 Solomon, B. D. et al. Mutations in ZIC2 in human holoprosencephaly: 
description of a novel ZIC2 specific phenotype and comprehensive analysis 
of 157 individuals. J Med Genet 47, 513-524, doi:10.1136/jmg.2009.073049 
(2010). 
3 Mercier, S. et al. New findings for phenotype-genotype correlations in a 
large European series of holoprosencephaly cases. J Med Genet 48, 752-760, 
doi:10.1136/jmedgenet-2011-100339 (2011). 
4 Warr, N. et al. Zic2-associated holoprosencephaly is caused by a transient 
defect in the organizer region during gastrulation. Hum Mol Genet 17, 2986-
2996, doi:10.1093/hmg/ddn197 (2008). 
5 Nagai, T. et al. Zic2 regulates the kinetics of neurulation. Proc Natl Acad 
Sci U S A 97, 1618-1623 (2000). 
6 Elms, P. et al. Overlapping and distinct expression domains of Zic2 and 
Zic3 during mouse gastrulation. Gene Expr Patterns 4, 505-511, 
doi:10.1016/j.modgep.2004.03.003 (2004). 
7 Conlon, F. L. et al. A primary requirement for nodal in the formation and 
maintenance of the primitive streak in the mouse. Development 120, 1919-
1928 (1994). 
8 Houtmeyers, R. et al. Zic2 mutation causes holoprosencephaly via disruption 
of NODAL signalling. Hum Mol Genet, doi:10.1093/hmg/ddw235 (2016). 
9 Norris, D. P. Cilia, calcium and the basis of left-right asymmetry. BMC 
Biol 10, 102, doi:10.1186/1741-7007-10-102 (2012). 
10 Nonaka, S., Shiratori, H., Saijoh, Y. & Hamada, H. Determination of left-
right patterning of the mouse embryo by artificial nodal flow. Nature 418, 
96-99, doi:10.1038/nature00849 (2002). 
11 Collignon, J., Varlet, I. & Robertson, E. J. Relationship between 
asymmetric nodal expression and the direction of embryonic turning. Nature 
381, 155-158, doi:10.1038/381155a0 (1996). 
12 Lowe, L. A. et al. Conserved left-right asymmetry of nodal expression and 
alterations in murine situs inversus. Nature 381, 158-161, 
doi:10.1038/381158a0 (1996). 
13 Brennan, J., Norris, D. P. & Robertson, E. J. Nodal activity in the node 
governs left-right asymmetry. Genes Dev 16, 2339-2344, 
doi:10.1101/gad.1016202 (2002). 
14 Saijoh, Y. et al. Distinct transcriptional regulatory mechanisms underlie 
left-right asymmetric expression of lefty-1 and lefty-2. Genes Dev 13, 259-
269 (1999). 
15 Ammirabile, G. et al. Pitx2 confers left morphological, molecular, and 
functional identity to the sinus venosus myocardium. Cardiovasc Res 93, 
291-301, doi:10.1093/cvr/cvr314 (2012). 
16 Chen, C. M., Norris, D. & Bhattacharya, S. Transcriptional control of left-
right patterning in cardiac development. Pediatr Cardiol 31, 371-377, 
doi:10.1007/s00246-009-9610-3 (2010). 
17 Dykes, I. M. Left Right Patterning, Evolution and Cardiac Development. J. 
Cardiovasc. Dev. Dis. 1, 52-72 (2014). 
18 Ramsdell, A. F. Left-right asymmetry and congenital cardiac defects: 
getting to the heart of the matter in vertebrate left-right axis 
determination. Dev Biol 288, 1-20, doi:10.1016/j.ydbio.2005.07.038 (2005). 
19 Nakamura, T. & Hamada, H. Left-right patterning: conserved and divergent 
mechanisms. Development 139, 3257-3262, doi:10.1242/dev.061606 (2012). 
20 Shiratori, H. & Hamada, H. The left-right axis in the mouse: from origin to 
morphology. Development 133, 2095-2104, doi:10.1242/dev.02384 (2006). 
21 Campione, M. & Franco, D. Current Perspectives in Cardiac Laterality. J 
Cardiovasc Dev Dis 3, doi:10.3390/jcdd3040034 (2016). 
22 Sutherland, M. J. & Ware, S. M. Disorders of left-right asymmetry: 
heterotaxy and situs inversus. Am J Med Genet C Semin Med Genet 151C, 307-
317, doi:10.1002/ajmg.c.30228 (2009). 
23 Mohapatra, B. et al. Identification and functional characterization of 
NODAL rare variants in heterotaxy and isolated cardiovascular 
malformations. Hum Mol Genet 18, 861-871, doi:10.1093/hmg/ddn411 (2009). 
24 Barratt, K. S., Glanville-Jones, H. C. & Arkell, R. M. The Zic2 gene 
directs the formation and function of node cilia to control cardiac situs. 
Genesis 52, 626-635, doi:10.1002/dvg.22767 (2014). 
25 Campione, M. et al. Pitx2 expression defines a left cardiac lineage of 
cells: evidence for atrial and ventricular molecular isomerism in the iv/iv 
mice. Dev Biol 231, 252-264, doi:10.1006/dbio.2000.0133 (2001). 
26 Matsuda, K. et al. ChIP-seq analysis of genomic binding regions of five 
major transcription factors in mouse epiblast stem cells that highlights a 
central role for ZIC2. Development, doi:10.1242/dev.143479 (2017). 
27 Luo, Z. et al. Zic2 is an enhancer-binding factor required for embryonic 
stem cell specification. Mol Cell 57, 685-694, 
doi:10.1016/j.molcel.2015.01.007 (2015). 
28 Kojima, Y. et al. The transcriptional and functional properties of mouse 
epiblast stem cells resemble the anterior primitive streak. Cell Stem Cell 
14, 107-120, doi:10.1016/j.stem.2013.09.014 (2014). 
29 Buecker, C. et al. Reorganization of enhancer patterns in transition from 
naive to primed pluripotency. Cell Stem Cell 14, 838-853, 
doi:10.1016/j.stem.2014.04.003 (2014). 
30 Hu, G. & Wade, P. A. NuRD and pluripotency: a complex balancing act. Cell 
Stem Cell 10, 497-503, doi:10.1016/j.stem.2012.04.011 (2012). 
31 Davies, B. et al. Site specific mutation of the Zic2 locus by 
microinjection of TALEN mRNA in mouse CD1, C3H and C57BL/6J oocytes. PLoS 
One 8, e60216, doi:10.1371/journal.pone.0060216 (2013). 
32 Bamforth, S. D. et al. Cited2 controls left-right patterning and heart 
development through a Nodal-Pitx2c pathway. Nat Genet 36, 1189-1196, 
doi:10.1038/ng1446 (2004). 
33 Scambler, P. J. 22q11 deletion syndrome: a role for TBX1 in pharyngeal and 
cardiovascular development. Pediatric cardiology 31, 378-390, 
doi:10.1007/s00246-009-9613-0 (2010). 
34 Dykes, I. M. et al. HIC2 is a novel dosage-dependent regulator of cardiac 
development located within the distal 22q11 deletion syndrome region. Circ 
Res 115, 23-31, doi:10.1161/CIRCRESAHA.115.303300 (2014). 
35 Szumska, D. et al. VACTERL/caudal regression/Currarino syndrome-like 
malformations in mice with mutation in the proprotein convertase Pcsk5. 
Genes Dev 22, 1465-1477, doi:10.1101/gad.479408 (2008). 
36 Schneider, J. E. et al. Identification of cardiac malformations in mice 
lacking Ptdsr using a novel high-throughput magnetic resonance imaging 
technique. BMC Dev Biol 4, 16, doi:10.1186/1471-213X-4-16 (2004). 
37 Elms, P., Siggers, P., Napper, D., Greenfield, A. & Arkell, R. Zic2 is 
required for neural crest formation and hindbrain patterning during mouse 
development. Dev Biol 264, 391-406 (2003). 
38 Seo, J. W., Brown, N. A., Ho, S. Y. & Anderson, R. H. Abnormal laterality 
and congenital cardiac anomalies. Relations of visceral and cardiac 
morphologies in the iv/iv mouse. Circulation 86, 642-650 (1992). 
39 Hildreth, V. et al. Left cardiac isomerism in the Sonic hedgehog null 
mouse. J Anat 214, 894-904, doi:10.1111/j.1469-7580.2009.01087.x (2009). 
40 Meno, C. et al. lefty-1 is required for left-right determination as a 
regulator of lefty-2 and nodal. Cell 94, 287-297 (1998). 
41 Yan, Y. T. et al. Conserved requirement for EGF-CFC genes in vertebrate 
left-right axis formation. Genes Dev 13, 2527-2537 (1999). 
42 Bartram, U., Wirbelauer, J. & Speer, C. P. Heterotaxy syndrome -- asplenia 
and polysplenia as indicators of visceral malposition and complex 
congenital heart disease. Biol Neonate 88, 278-290, doi:10.1159/000087625 
(2005). 
43 Oh, S. P. & Li, E. The signaling pathway mediated by the type IIB activin 
receptor controls axial patterning and lateral asymmetry in the mouse. 
Genes Dev 11, 1812-1826 (1997). 
44 Duboc, V., Rottinger, E., Lapraz, F., Besnardeau, L. & Lepage, T. Left-
right asymmetry in the sea urchin embryo is regulated by nodal signaling on 
the right side. Dev Cell 9, 147-158, doi:10.1016/j.devcel.2005.05.008 
(2005). 
45 Ryan, A. K. et al. Pitx2 determines left-right asymmetry of internal organs 
in vertebrates. Nature 394, 545-551, doi:10.1038/29004 (1998). 
46 Kawasumi, A. et al. Left-right asymmetry in the level of active Nodal 
protein produced in the node is translated into left-right asymmetry in the 
lateral plate of mouse embryos. Dev Biol 353, 321-330, 
doi:10.1016/j.ydbio.2011.03.009 (2011). 
47 Norris, D. P., Brennan, J., Bikoff, E. K. & Robertson, E. J. The Foxh1-
dependent autoregulatory enhancer controls the level of Nodal signals in 
the mouse embryo. Development 129, 3455-3468 (2002). 
48 Adachi, H. et al. Determination of left/right asymmetric expression of 
nodal by a left side-specific enhancer with sequence similarity to a lefty-
2 enhancer. Genes Dev 13, 1589-1600 (1999). 
49 Papanayotou, C. et al. A novel nodal enhancer dependent on pluripotency 
factors and smad2/3 signaling conditions a regulatory switch during 
epiblast maturation. PLoS Biol 12, e1001890, 
doi:10.1371/journal.pbio.1001890 (2014). 
50 Vincent, S. D., Dunn, N. R., Hayashi, S., Norris, D. P. & Robertson, E. J. 
Cell fate decisions within the mouse organizer are governed by graded Nodal 
signals. Genes Dev 17, 1646-1662, doi:10.1101/gad.1100503 (2003). 
51 Norris, D. P. & Robertson, E. J. Asymmetric and node-specific nodal 
expression patterns are controlled by two distinct cis-acting regulatory 
elements. Genes Dev 13, 1575-1588 (1999). 
52 Purandare, S. M. et al. A complex syndrome of left-right axis, central 
nervous system and axial skeleton defects in Zic3 mutant mice. Development 
129, 2293-2302 (2002). 
53 Jiang, Z. et al. Zic3 is required in the extra-cardiac perinodal region of 
the lateral plate mesoderm for left-right patterning and heart development. 
Hum Mol Genet 22, 879-889, doi:10.1093/hmg/dds494 (2013). 
54 Ware, S. M., Harutyunyan, K. G. & Belmont, J. W. Heart defects in X-linked 
heterotaxy: evidence for a genetic interaction of Zic3 with the nodal 
signaling pathway. Dev Dyn 235, 1631-1637, doi:10.1002/dvdy.20719 (2006). 
55 Brown, L., Paraso, M., Arkell, R. & Brown, S. In vitro analysis of partial 
loss-of-function ZIC2 mutations in holoprosencephaly: alanine tract 
expansion modulates DNA binding and transactivation. Hum Mol Genet 14, 411-
420, doi:10.1093/hmg/ddi037 (2005). 
56 Lowe, L. A., Yamada, S. & Kuehn, M. R. Genetic dissection of nodal function 
in patterning the mouse embryo. Development 128, 1831-1843 (2001). 
57 Beckers, A., Alten, L., Viebahn, C., Andre, P. & Gossler, A. The mouse 
homeobox gene Noto regulates node morphogenesis, notochordal ciliogenesis, 
and left right patterning. Proc Natl Acad Sci U S A 104, 15765-15770, 
doi:10.1073/pnas.0704344104 (2007). 
58 Saijoh, Y., Oki, S., Ohishi, S. & Hamada, H. Left-right patterning of the 
mouse lateral plate requires nodal produced in the node. Dev Biol 256, 160-
172 (2003). 
59 Raya, A. et al. Notch activity induces Nodal expression and mediates the 
establishment of left-right asymmetry in vertebrate embryos. Genes Dev 17, 
1213-1218, doi:10.1101/gad.1084403 (2003).Shiratori, H. & Hamada, H. 
TGFbeta signaling in establishing left-right asymmetry. Semin Cell Dev Biol 
32, 80-84, doi:10.1016/j.semcdb.2014.03.029 (2014). 
60 Tanaka, C., Sakuma, R., Nakamura, T., Hamada, H. & Saijoh, Y. Long-range 
action of Nodal requires interaction with GDF1. Genes Dev 21, 3272-3282, 
doi:10.1101/gad.1623907 (2007). 
61 Kitajima K, Oki S, Ohkawa Y, Sumi T, Meno C. Wnt signaling regulates left-
right axis formation in the node of mouse embryos. Dev Biol.380,222-32. 
doi: 10.1016/j.ydbio.2013.05.011 (2013). 
62 Field, S. et al. Pkd1l1 establishes left-right asymmetry and physically 
interacts with Pkd2. Development 138, 1131-1142, doi:10.1242/dev.058149 
(2011). 
  
63 Crocker, J., Noon, E. P. & Stern, D. L. The Soft Touch: Low-Affinity 
Transcription Factor Binding Sites in Development and Evolution. Curr Top 
Dev Biol 117, 455-469, doi:10.1016/bs.ctdb.2015.11.018 (2016). 
64 Bentham, J. et al. Maternal high-fat diet interacts with embryonic Cited2 
genotype to reduce Pitx2c expression and enhance penetrance of left-right 
patterning defects. Hum Mol Genet 19, 3394-3401, doi:10.1093/hmg/ddq251 
(2010). 
65 Schneider, J. E. et al. Rapid identification and 3D reconstruction of 
complex cardiac malformations in transgenic mouse embryos using fast 
gradient echo sequence magnetic resonance imaging. J Mol Cell Cardiol 35, 
217-222 (2003). 
66 Gentleman, R. C. et al. Bioconductor: open software development for 
computational biology and bioinformatics. Genome Biol 5, R80, 
doi:10.1186/gb-2004-5-10-r80 (2004). 
67 Huber, W., von Heydebreck, A., Sultmann, H., Poustka, A. & Vingron, M. 
Variance stabilization applied to microarray data calibration and to the 
quantification of differential expression. Bioinformatics 18 Suppl 1, S96-
104 (2002). 
68 Smyth, G. K. in Bioinformatics and Computational Biology Solutions using R 
and Bioconductor   (ed R. C. Gentleman)  397-420 (Springer-Verlag, 2005). 
69 Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate - a 
Practical and Powerful Approach to Multiple Testing. Journal of the Royal 
Statistical Society Series B-Methodological 57, 289-300 (1995). 
70 Ulitsky, I. et al. Expander: from expression microarrays to networks and 
functions. Nat Protoc 5, 303-322, doi:10.1038/nprot.2009.230 (2010). 
71 Correia, K. M. & Conlon, R. A. Whole-mount in situ hybridization to mouse 
embryos. Methods 23, 335-338, doi:10.1006/meth.2000.1145 (2001). 
72 Robinson, J. T. et al. Integrative genomics viewer. Nat Biotechnol 29, 24-
26, doi:10.1038/nbt.1754 (2011). 
 
  
FIGURE LEGENDS 
 
Figure 1. Holoprosencephaly, spina bifida and cyclopia in the Zic2 mouse mutant  
Representative images illustrating a wildtype E14.5 embryo (a, a1-a5) and a Zic2A5/A5 
embryo (b, b1-b5) at E14.5. Dashed red lines in a and b indicate the level of sections shown 
below. The mutant embryo exhibits alobar holoprosencephaly indicated by a lack of 
separation in forebrain structures (b1, b2), cyclopia (b3), spina bifida (b4, b5 arrows) and 
right pulmonary isomerism (b4). 
Abbreviations: V-D – ventral – dorsal; R-L – right – left; MO – medulla oblongata; SC – 
spinal cord; SCC – semi-circular canal; TG – trigeminal ganglion; TV – telencephalic vesicle; 
CS- corpus striatum; P – pinna; E – eye(s); L – lungs; Liv – liver; K – kidneys. 
 
Figure 2. Cardiovascular, pulmonary and visceral phenotypes in the Zic2 mouse 
mutant 
Representative images illustrating range of phenotypes observed in wildtype (a,c,e,g,i,k,m,o) 
and homozygous mutants (iso and TALEN ; b,d,f,h,j,l,n,p) at E14.5.  
a, b Holoprosencephaly (HPE), spina bifida (SB) and curly tail (T)  
c, d Reversed ventricular topology. The left ventricle (LV) is dextral to the right (RV), which 
gives rise to both Ao and PA (double-outlet right ventricle). 
e ,f Right atrial isomerism indicated by bilateral systemic venous sinuses (SVS) and a large 
atrio-ventricular septal defect (asterisk). 
g, h Systemic and pulmonary veins (dorsal view). In the control embryo, the great veins 
(Inferior vena cava (IVC), left superior vena cava (LSVC), right superior vena cava (RSVC)) 
converge to form the systemic venous sinus which drains into the right atrium (RA) while the 
pulmonary veins (PV) drain into the left atrium (red asterisk). The azygos vein (AV) drains 
into the LSVC just above the level of the atria. In the mutant embryo, the IVC is left-sided 
while the hepatic vein (HV) and PV also drain into sinus venosus (red asterisk) which opens 
bilaterally into the atria. The AV is duplicated. 
i,j Hepatic venous anatomy (ventral view). In the wildtype, the IVC passes through the liver 
(grey shading) to drain into the right atrium (red arrowhead) and is connected to the umbilical 
vein (UV). In the mutant embryo, the IVC drains into the left atrium. The UV connects to the 
right hepatic vein (HV) which drains directly into the right atrium (red arrowheads). 
k,l Right-sided aortic arch (AoA). The descending aorta (Dao) may be seen to be ectopically 
located to the right of the trachea (Tr) in the mutant. 
m. n Right pulmonary isomerism. H – heart; LL – left lung; Cr – cranial lobe; Mi – middle 
lobe; Ca – caudal lobe; Ac – accessory lobe. 
o, p Ectopic right sided stomach (S). Liv – liver; S – stomach; UAs – umbilical arteries. 
  
Figure 3. Loss of Zic2 leads to downregulation of the NODAL pathway 
a, b. Microarray analysis of gene expression changes in the Zic2iso/iso embryo compared to 
wildtype at E8.5. a. Volcano plot. The data are plotted as log fold change (relative to 
wildtype) against adjusted p-value. b. Heat map showing wildtype (WT; left panel) and 
Zic2iso/iso (KO; right panel) embryos. Data show mean expression for three independent 
biological replicates of pooled embryos and are expressed as log2 values.  
c.  SYBR Green based qRT-PCR analysis of genes identified in the microarray screen, and 
known NODAL pathway genes. Expression values shown are normalised to Gapdh. Three 
independent biological replicates of pooled embryos (0-4 somites) were performed for each 
condition and these are plotted as individual data points (blue circles indicate wildtype; 
orange triangles indicate Zic2iso/iso ). Asterisks above each column indicate result of a one 
tailed t-test of samples with unequal variance testing the null hypothesis that loss of Zic2 has 
no effect on gene expression: ***p<0.0005; **p<0.005; * p<0.05, NS = not significant. 
d. Taqman qRT-PCR analysis of Pitx2c expression at three different ages (2-4 somites, 4-6 
somites and 12-25 somites). Three independent biological replicates of pooled embryos 
were performed for each condition. Labels as per panel c. 
 
Figure 4.   Disrupted left-side specification in the Zic2 mutant 
 (a-b; d-g; i-l; o-r; t,u) in situ hybridisation. Genotype and age of embryos (expressed as 
somite number) are indicated. All images are oriented with the left side on the right of the 
photo and show the ventral surface of the embryo. Arrows indicate LPM, arrowheads: node. 
t and u are composite images.  
(c,h,m,n,s) Charts summarise the results of in situ experiments illustrating the relationship of 
expression pattern and expression level to embryo age and genotype. Each dot represents 
an individual embryo, blue dots are control embryos (+/+ and +/iso), red are mutants 
(iso/iso). A dark colour indicates strong expression while a lighter colour indicates weak or 
absent expression. Data are plotted as expression pattern (one of 4 categories shown on the 
x axis) against embryo age (expressed as somite number: 1s, 2s etc., y axis). HF = headfold 
stage.  L = left, R = right.  
 
Figure 5: ZIC2 binds to the Nodal locus and promotes transcriptional activation 
a. ChIP-seq data to show ZIC2 binding at the Nodal locus in embryonic stem cells (ESC)27 
and in epiblast stem cells (EpiSC)26. The five previously-characterised enhancer elements 
are indicated by yellow boxes in the cartoon above, while exons are indicated by blue boxes. 
Coloured dots in the cartoon indicate putative ZIC2 binding sites. In ESCs (upper trace), two 
high-affinity binding sites are seen, located within the PEE and HBE enhancers (green dots). 
In EpiSCs (lower trace), four high-affinity sites are observed which includes the two bound in 
ESCs (green dots) as well as two additional sites located within the NDE and HBE 
enhancers (red dots). Several lower-affinity binding sites map to ASE, HBE and exon 1, the 
site located within HBE is indicated by a blue dot.   
b.  Luciferase assays performed using reporter constructs consisting of each of the known 
Nodal enhancers linked to a viral E1b promoter and luciferase, as shown in the cartoon. Blue 
circles indicate control transfections, orange triangles ZIC2 transfections. Luciferase activity 
is plotted relative to control.  
The data show that the HBE reporter is activated by ZIC2 above background. 
c.  Luciferase assays using the native HBE reporter, performed as in b. Cells were 
transfected with the reporter and an expression plasmid for ZIC3, ZIC2 or ZIC2-ISO, or a 
control empty vector (pcDNA).  
d. Luciferase assays using modified HBE reporters, performed as in b. HBE contains 3 
putative ZIC2 binding sites, indicated by the coloured dots in the cartoon, deleted binding 
sites are indicated by an “X”. Deletion of sites ZBS1 and ZBS2 (red and green dots in the 
cartoon) has no effect on the ability of ZIC2 to activate the reporter, while deletion of site 
ZBS3 (blue dot) eliminates this activity.  
e. Gel shift (EMSA) assays to study the binding of ZIC2 to HBE. P =probe only, Z = probe + 
HA-ZIC2, ZC = probe + HA-ZIC2 + unlabelled competitor, ZA = probe + HA-ZIC2+ αHA 
antibody. Red arrow = gel shift, blue arrow = supershift. Images show cropped gel pictures, 
uncropped images are shown in the supplemental data. 
 
 
Table 1. Cardiovascular defects, pulmonary and visceral situs defects and 
holoprosencephaly in human patients with ZIC2 mutation. 
 
Notes 
1. DNA co-ordinates are shown for the cDNA sequence starting from the beginning of 
the coding sequence. 
2. MTP = medical termination of pregnancy 
3. Severity of HPE phenotype: Alobar > Semilobar > Lobar > Syntelencephaly 
4. A single base deletion leads to a frameshift error resulting in translation of a false 
sequence with a stop codon after 57 amino acids. 
 
 
Table 2 Cardiovascular and situs defects identified in Zic2 mutants. 
A summary of the phenotypes observed by MRI and µCT imaging in all Zic2 mutants 
examined including both the original iso line and TALEN-generated lines.  All embryos are 
homozygous mutants, except for those labelled “trans-hets” which carry one iso allele and 
one TALEN allele as a test of complementarity. For each phenotype described, the first 
number indicates the number of embryos observed with that phenotype, while the second 
indicates the number examined. The latter number differs for different phenotypes because it 
was not possible to assess every phenotype in every embryo due to limitations of imaging. 
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Table 1. Association of cardiovascular and situs defects with holoprosencephaly in human cases with ZIC2 mutation. 
 
Proband Gender Survival Mutation 
 
Isolated 
/Syndromic
Type of HPE3 Heart malformations Other visceral anomalies 
DNA1 Protein 
1 F Fœtus 
MTP2 
107A>C p.(Gln36Pro) I Semilobar N/A Renal hypoplasia, 
Pulmonary hypoplasia,  
Adrenal hypoplasia, 
Spleen hypoplasia 
2 F Fœtus 
MTP 
466C>T p.(His156Tyr) S Semilobar Hypoplastic 
ascendant aorta,  
VSD 
Single umbilical artery 
3 F Fœtus 
MTP 
941T>G p.(Phe314Cys) S Pseudo-anencephaly Hypoplastic 
ascendant aorta, 
Aortic stenosis, 
VSD 
Diaphragmatic hernia, 
Unilateral renal agenesis, 
Unicorn uterus 
4 F Fœtus 
MTP 
1377-1406
del 
Alanine tract 
deletion 
(aa456-465) 
S Lobar N/A Pulmonary hypoplasia  
Abnormal lung lobulation, 
Common mesentery, 
Single umbilical artery 
5 F Fœtus 
MTP 
1377-1406
dup 
Alanine tract 
expansion 
(increased to 
25 from 15) 
I Semilobar Subaortic VSD Single umbilical artery 
6 M Fœtus 
MTP 
1493 
delG 
p. (Gly498A 
fs*57)4 
S Semilobar VSD  
7 M Fœtus 
MTP 
13q 
deletion 
N/A S Alobar Duplicated superior 
vena cava 
Tetralogy of Fallot 
Ductus arteriosus 
agenesis 
Bilobulated lung 
Gallbladder agenesis 
8 M Born 
alive 
Whole 
gene 
deletion 
N/A I Syntelencephaly Heart defect 
(not documented) 
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Table 2. Neural tube, visceral and cardiovascular defects identified in mouse Zic2 mutants. 
  
  
  
  
  
  
iso TALEN Trans-hets
iso/iso A5/A5 A10/A10  
& 
A17/A17 
A19/A19 iso/
A5 
iso/
A8 
Neural 
Tube 
Defects 
  
  
Exencephaly 17/17 10/10 3/3 3/3 2/2 2/2 
Holoprosencephaly Alobar 13/16 5/7 3/3 2/3 2/2 2/2 
Semilobar 3/16 2/7 0/3 1/3 0/2 0/2 
Lobar 0/16 0/7 0/3 0/3 0/2 0/2 
Eyes Cyclopia 8/17 3/7 1/3 2/3 1/2 2/2 
Hypotelorism 6/17 3/7 1/3 0/3 0/2 0/2 
Absent 3/17 0/7 1/3 1/3 1/2 0/2 
Spina bifida 17/17 10/10 3/3 3/3 2/2 2/2 
Curly tail 17/17 10/10 3/3 3/3 2/2 2/2 
  
  
      
Viscera 
  
  
  
  
  
  
Lungs  Right Isomerism 13/17 6/10 2/3 3/3 1/2 2/2 
Left Isomerism 0/17 1/10 0/3 0/3 0/2 0/2
Reversed 0/17 0/10 0/3 0/3 0/2 0/2 
Normal 4/17 3/10 1/3 0/3 1/2 0/2
Spleen  Reduced or absent 1/6 4/7 0/2 0/0 0/1 0/0 
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                  Duplicated 0/6 0/7 0/2 0/0 0/1 0/0 
Right sided 2/6 0/7 0/2 0/0 0/1 0/0
Heart Dextrocardia 4/16 4/10 0/3 2/3 0/2 1/2 
Mesocardia 7/16 2/10 0/3 1/3 2/2 1/2 
Stomach Right sided 7/17 2/10 0/3 0/3 0/2 2/2 
Pancreas Right sided 5/14 2/7 0/3 0/2 0/2 0/0 
       
Atria &  
Veins 
  
  
  
Bilateral systemic venous sinus 10/15 4/10 1/3 3/3 1/2 2/2 
Left sided Inferior vena cava 5/16 3/10 0/3 1/3 0/2 2/2
Hepatic vein drainage direct to atria 2/16 3/10 0/3 3/3 0/2 0/2 
Atrial septal defect 8/11 5/10 1/3 2/2 1/2 2/2
  
  
      
Ventricles 
& Arteries 
  
  
  
Abnormal ventricular topology 6/13 6/10 0/3 1/2 1/2 2/2 
Great artery transposition 0/13 0/10 1/3 0/3 0/2 0/2 
Double outlet right ventricle 5/13 5/9 0/3 2/3 0/2 2/2
Ventricular septal defect 11/15 7/10 0/3 1/1 2/2 2/2 
Rightward looped aortic arch 5/17 3/10 1/3 2/3 0/2 0/2
 
 
 
 





